Medicare Enrolled

Dr. Jorge Darcourt, M.D.

Hematology & Oncology · Sugar Land, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
16659 SOUTHWEST FWY, Sugar Land, TX 77479
2812765200
In practice since 2008 (17 years)
NPI: 1811133697 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Darcourt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Darcourt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Darcourt

Dr. Jorge Darcourt is a hematology & oncology specialist in Sugar Land, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Darcourt performed 5,950 Medicare services across 842 unique beneficiaries.

Between the years covered by Open Payments, Dr. Darcourt received a total of $114,349 from 34 pharmaceutical and/or device companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Darcourt is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 39% volume in TX $114,349 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,950
Medicare services
Top 39% in TX for hematology & oncology
842
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~350 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Anti-nausea injection (fosaprepitant)
An injection of fosaprepitant, a medication used to prevent nausea and vomiting.
2,100 $0 $5
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
1,100 $0 $3
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
545 $8 $20
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
510 $0 $1
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
495 $8 $36
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
364 $61 $250
Anti-nausea injection (Aloxi/palonosetron) 150 $1 $114
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
98 $92 $368
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
92 $8 $431
Intensity-modulated radiation therapy delivery
Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session.
65 $271 $2,762
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
59 $98 $707
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
58 $22 $157
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
48 $10 $64
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
34 $12 $108
Reticulated platelet measurement
A blood test that measures the level of young, newly formed platelets in the body.
30 $35 $143
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
30 $44 $313
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
29 $11 $96
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
24 $61 $247
Manual white blood cell count
A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present.
22 $4 $22
Complete blood count (CBC), automated
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood.
21 $6 $34
New patient office visit, complex (60-74 min) 21 $164 $709
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
19 $49 $344
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
18 $1,059 $4,802
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 18 $88 $657
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.8% high complexity
68.9% medium
28.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$114,349
Total received (2018-2024)
Avg $16,336/year across 7 years
Top 6% in TX for hematology & oncology
34
Companies
211
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$65,303 (57.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$46,606 (40.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,440 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$59,525
2023
$28,945
2022
$15,950
2021
$8,964
2020
$489
2019
$279
2018
$197

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$60,032
Lilly USA, LLC
$39,321
Eli Lilly and Company
$10,800
Daiichi Sankyo Inc.
$1,314
PFIZER INC.
$554
Astellas Pharma US Inc
$542
Novartis Pharmaceuticals Corporation
$311
Celgene Corporation
$251
GENZYME CORPORATION
$166
Bayer HealthCare Pharmaceuticals Inc.
$101
Secura Bio, Inc.
$88
E.R. Squibb & Sons, L.L.C.
$86
AstraZeneca Pharmaceuticals LP
$85
SOBI, INC
$69
MorphoSys, US Inc.
$65
Genentech USA, Inc.
$46
Merck Sharp & Dohme LLC
$45
Incyte Corporation
$45
Tempus AI, Inc
$44
Stemline Therapeutics Inc.
$42
Amgen Inc.
$35
SpringWorks Therapeutics, Inc.
$33
TerSera Therapeutics LLC
$33
Eisai Inc.
$29
Apellis Pharmaceuticals, Inc.
$28
Janssen Pharmaceuticals, Inc
$27
BeiGene USA, Inc.
$23
AVEO Pharmaceuticals, Inc.
$22
Puma Biotechnology, Inc.
$22
ABBVIE INC.
$20
Janssen Biotech, Inc.
$19
Global Blood Therapeutics, Inc.
$19
Karyopharm Therapeutics Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$16
Top 3 companies account for 96.3% of total payments
Associated products mentioned in payments ›
Alecensa · BOSULIF · BRUKINSA · CALQUENCE · COPIKTRA · ENHERTU · ENJAYMO · Enhertu · FOTIVDA · Fabhalta · IBRANCE · IMBRUVICA · IMJUDO · INLYTA · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · Lenvima · MONJUVI · OGSIVEO · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PROMACTA · Pomalyst · REBLOZYL · SARCLISA · SCEMBLIX · SYNAGIS · TALZENNA · Trodelvy · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vitrakvi · XARELTO · XPOVIO · XTANDI · XYNTHA · Xospata · Xtandi · Yescarta · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (57%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for hematology & oncology in TX.

Equivalent to $1,922 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Sugar Land?
Compare hematology & oncology specialists in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
184
Per 100K population
21.4
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Darcourt is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 6% of TX peers, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Darcourt experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Darcourt performed 2,100 anti-nausea injection (fosaprepitant) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Darcourt receive payments from pharmaceutical companies?
Yes. Dr. Darcourt received a total of $114,349 from 34 companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Darcourt's costs compare to other hematology & oncology specialists in Sugar Land?
Dr. Darcourt's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Darcourt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →